Novo Nordisk shares dropped as low as $46.90 in Thursday’s session, their lowest level since January 2022, following a profit warning.

Novo Nordisk on Tuesday slashed its forecast for 2025 sales growth due to competition from compounded, or copycat, versions ...

Eli Lilly’s trial evaluating Mounjaro in reducing cardiovascular risk met its endpoint, though missed analyst expectations.

European pharma stocks fell after President Trump [wrote to 17 companies]( ...

At their peak last year, one share in the company Novo Nordisk cost $142; now, they can be bought for under $50.

European stocks hit a 4-week low on Friday at the end of a busy week as investors worried about the impact of fresh US levies ...

Investing.com - Shares of European drugmakers fell on Friday after President Donald Trump issued letters to more than a dozen pharmaceutical groups arguing for them to lower U.S. prescription drug ...

It came as Mr Trump imposed sweeping tariffs on trading partners including a 35pc levy on neighbouring Canada, in a move that ...

European stock markets are poised for a lower open on Friday, with futures pointing to declines across most major bourses.

The U.S. will raise tariffs on scores of nations, effective at 12:01 a.m. on Aug. 7, according to an executive order Trump signed on Thursday. When the action is taken, the result will be ...

Novo Nordisk shares dropped Thursday morning, falling nearly 5% at the opening of the Danish stock exchange before recovering slightly to a 4.2% loss. The share briefly dipped below 300 kroner, its ...

Bloomberg journalists discuss today's biggest winners and losers in the stock market. Listen for analysis on the companies ...